These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 27146458)
1. RBFOX1 and RBFOX2 are dispensable in iPSCs and iPSC-derived neurons and do not contribute to neural-specific paternal UBE3A silencing. Chen PF; Hsiao JS; Sirois CL; Chamberlain SJ Sci Rep; 2016 May; 6():25368. PubMed ID: 27146458 [TBL] [Abstract][Full Text] [Related]
3. Regulation of the large (approximately 1000 kb) imprinted murine Ube3a antisense transcript by alternative exons upstream of Snurf/Snrpn. Landers M; Bancescu DL; Le Meur E; Rougeulle C; Glatt-Deeley H; Brannan C; Muscatelli F; Lalande M Nucleic Acids Res; 2004; 32(11):3480-92. PubMed ID: 15226413 [TBL] [Abstract][Full Text] [Related]
4. Angelman syndrome-derived neurons display late onset of paternal UBE3A silencing. Stanurova J; Neureiter A; Hiber M; de Oliveira Kessler H; Stolp K; Goetzke R; Klein D; Bankfalvi A; Klump H; Steenpass L Sci Rep; 2016 Aug; 6():30792. PubMed ID: 27484051 [TBL] [Abstract][Full Text] [Related]
5. Towards a therapy for Angelman syndrome by targeting a long non-coding RNA. Meng L; Ward AJ; Chun S; Bennett CF; Beaudet AL; Rigo F Nature; 2015 Feb; 518(7539):409-12. PubMed ID: 25470045 [TBL] [Abstract][Full Text] [Related]
6. Ube3a-ATS is an atypical RNA polymerase II transcript that represses the paternal expression of Ube3a. Meng L; Person RE; Beaudet AL Hum Mol Genet; 2012 Jul; 21(13):3001-12. PubMed ID: 22493002 [TBL] [Abstract][Full Text] [Related]
7. Enhanced Nociception in Angelman Syndrome Model Mice. McCoy ES; Taylor-Blake B; Aita M; Simon JM; Philpot BD; Zylka MJ J Neurosci; 2017 Oct; 37(42):10230-10239. PubMed ID: 28931574 [TBL] [Abstract][Full Text] [Related]
8. Neurons but not glial cells show reciprocal imprinting of sense and antisense transcripts of Ube3a. Yamasaki K; Joh K; Ohta T; Masuzaki H; Ishimaru T; Mukai T; Niikawa N; Ogawa M; Wagstaff J; Kishino T Hum Mol Genet; 2003 Apr; 12(8):837-47. PubMed ID: 12668607 [TBL] [Abstract][Full Text] [Related]
9. Dynamic developmental regulation of the large non-coding RNA associated with the mouse 7C imprinted chromosomal region. Le Meur E; Watrin F; Landers M; Sturny R; Lalande M; Muscatelli F Dev Biol; 2005 Oct; 286(2):587-600. PubMed ID: 16126194 [TBL] [Abstract][Full Text] [Related]
10. Cas9 gene therapy for Angelman syndrome traps Ube3a-ATS long non-coding RNA. Wolter JM; Mao H; Fragola G; Simon JM; Krantz JL; Bazick HO; Oztemiz B; Stein JL; Zylka MJ Nature; 2020 Nov; 587(7833):281-284. PubMed ID: 33087932 [TBL] [Abstract][Full Text] [Related]
11. Loss of non-coding RNA expression from the DLK1-DIO3 imprinted locus correlates with reduced neural differentiation potential in human embryonic stem cell lines. Mo CF; Wu FC; Tai KY; Chang WC; Chang KW; Kuo HC; Ho HN; Chen HF; Lin SP Stem Cell Res Ther; 2015 Jan; 6(1):1. PubMed ID: 25559585 [TBL] [Abstract][Full Text] [Related]
12. LncRNA ZFAS1 promotes laryngeal cancer progression through RBFOX2-mediated MENA alternative splicing. Lu B; Li X; Miao W; Liu Q; Li R; Cui C; Gao Q; Lian R Environ Toxicol; 2023 Mar; 38(3):522-533. PubMed ID: 36336961 [TBL] [Abstract][Full Text] [Related]
13. MBNL1 and RBFOX2 cooperate to establish a splicing programme involved in pluripotent stem cell differentiation. Venables JP; Lapasset L; Gadea G; Fort P; Klinck R; Irimia M; Vignal E; Thibault P; Prinos P; Chabot B; Abou Elela S; Roux P; Lemaitre JM; Tazi J Nat Commun; 2013; 4():2480. PubMed ID: 24048253 [TBL] [Abstract][Full Text] [Related]
14. Toward a Broader View of Ube3a in a Mouse Model of Angelman Syndrome: Expression in Brain, Spinal Cord, Sciatic Nerve and Glial Cells. Grier MD; Carson RP; Lagrange AH PLoS One; 2015; 10(4):e0124649. PubMed ID: 25894543 [TBL] [Abstract][Full Text] [Related]
15. SNURF-SNRPN and UBE3A transcript levels in patients with Angelman syndrome. Runte M; Kroisel PM; Gillessen-Kaesbach G; Varon R; Horn D; Cohen MY; Wagstaff J; Horsthemke B; Buiting K Hum Genet; 2004 May; 114(6):553-61. PubMed ID: 15014980 [TBL] [Abstract][Full Text] [Related]
16. Imprinting effects of UBE3A loss on synaptic gene networks and Wnt signaling pathways. Lopez SJ; Laufer BI; Beitnere U; Berg EL; Silverman JL; O'Geen H; Segal DJ; LaSalle JM Hum Mol Genet; 2019 Nov; 28(22):3842-3852. PubMed ID: 31625566 [TBL] [Abstract][Full Text] [Related]
17. Characterization and structure-activity relationships of indenoisoquinoline-derived topoisomerase I inhibitors in unsilencing the dormant Lee HM; Clark EP; Kuijer MB; Cushman M; Pommier Y; Philpot BD Mol Autism; 2018; 9():45. PubMed ID: 30140420 [TBL] [Abstract][Full Text] [Related]
18. Generation of an iPSC line of a patient with Angelman syndrome due to an imprinting defect. Neureiter A; Brändl B; Hiber M; Tandon R; Müller FJ; Steenpass L Stem Cell Res; 2018 Dec; 33():20-24. PubMed ID: 30296670 [TBL] [Abstract][Full Text] [Related]
19. A high-fidelity RNA-targeting Cas13 restores paternal Ube3a expression and improves motor functions in Angelman syndrome mice. Li J; Shen Z; Liu Y; Yan Z; Liu Y; Lin X; Tang J; Lv R; Geng G; Xiong ZQ; Zhou C; Yang H Mol Ther; 2023 Jul; 31(7):2286-2295. PubMed ID: 36805082 [TBL] [Abstract][Full Text] [Related]
20. Persistent neuronal Ube3a expression in the suprachiasmatic nucleus of Angelman syndrome model mice. Jones KA; Han JE; DeBruyne JP; Philpot BD Sci Rep; 2016 Jun; 6():28238. PubMed ID: 27306933 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]